Anti-SRP myositis: a diagnostic and therapeutic challenge
Open Access
- 19 December 2024
- journal article
- research article
- Published by Hacettepe University Institute of Child Health in The Turkish Journal of Pediatrics
- Vol. 66 (6) , 792-800
Abstract
Background. Anti-signal recognition protein (anti-SRP) myopathy is a rare idiopathic inflammatory myopathy in children. Herein, a 3-year-old patient with severe anti-SRP myopathy showing a rapidly progressive disease course is presented in order to increase the awareness of pediatricians about idiopathic inflammatory myopathies. Case Presentation. A previously healthy 3-year-old girl presented with progressive symmetrical proximal muscle weakness that caused difficulty in climbing stairs for two months prior to evaluation, and a marked elevation of the serum creatine kinase levels. A skeletal muscle biopsy revealed necrotic and regenerating processes, with mild inflammatory changes. Myositis-specific and associated autoantibodies tested by the immunoblot method were positive for anti-SRP. Pulse corticosteroid, intravenous immunoglobulin, and methotrexate were administered. However, muscle weakness progressed, respiratory distress and dysphagia developed. Rituximab was initiated. While on rituximab treatment, she was able to walk independently and muscle enzymes were within normal range at the 15th month of diagnosis. Conclusion. Early diagnosis of patients with anti-SRP myositis is important to control inflammation and prevent disease progression and complications. To our knowledge, our patient is the youngest case reported in the literature and was successfully treated with rituximab added to conventional therapy.Keywords
This publication has 20 references indexed in Scilit:
- Juvenile idiopathic inflammatory myositis: an update on pathophysiology and clinical careNature Reviews Rheumatology, 2023
- Muscular dystrophiesThe Lancet, 2019
- Juvenile Idiopathic Inflammatory MyopathiesPediatric Clinics of North America, 2018
- Sporadic acute benign calf myositis: Systematic literature reviewNeuromuscular Disorders, 2018
- Association of Anti–3‐Hydroxy‐3‐Methylglutaryl‐Coenzyme A Reductase Autoantibodies With DRB1*07:01 and Severe Myositis in Juvenile Myositis PatientsArthritis Care & Research, 2017
- Childhood autoimmune necrotizing myopathy with anti-signal recognition particle antibodiesMuscle & Nerve, 2017
- Tacrolimus in combination with methotrexate and corticosteroid for the treatment of child-onset anti-signal recognition particle antibody-positive necrotizing myopathyScandinavian Journal of Rheumatology, 2016
- A pediatric patient with myopathy associated with antibodies to a signal recognition particleBrain and Development, 2012
- Anti-Signal Recognition Particle Myopathy in the First Decade of LifePediatric Neurology, 2011
- A broadened spectrum of juvenile myositis. myositis‐specific autoantibodies in childrenArthritis & Rheumatism, 1994